Mitral Valve Insufficiency
96
9
17
42
Key Insights
Highlights
Success Rate
81% trial completion
Published Results
24 trials with published results (25%)
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 59/100
10.4%
10 terminated out of 96 trials
80.8%
-5.7% vs benchmark
9%
9 trials in Phase 3/4
57%
24 of 42 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 42 completed trials
Clinical Trials (96)
ProspeCtive, nOn-randoMized, MulticENter Clinical Evaluation of Edwards Pericardial Bioprostheses With a New Tissue Treatment Platform (COMMENCE)
REvascularization and Valve Intervention for Ischemic Valve diseasE: REVIVE Trial
Real-world Clinical Outcomes of the MITRIS RESILIA Mitral Valve
The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
Randomized Trial of the Neochord DS1000 System Versus Open Surgical Repair
Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Transcatheter Mitral Valve System for the Treatment of Symptomatic Mitral Regurgitation
The ENCIRCLE Trial
Transcatheter Mitral Valve Replacement System (TMVR) Pilot Study and The Early Feasibility Study of the TMVR Transseptal System
DragonFly EU Pivotal Study
PARTNER 3 Trial - Mitral Valve in Valve
Belgian Mitraclip Registry
Long Term Follow Up for CTSN Mitral Valve Repair Studies
Korea VHD Echo Study: Surveillance of Aortic, Mitral & Tricuspid Patients - Insights From Real-world Practice
Aortic or Mitral Valve Replacement With the Braile Biomédica® Bovine Pericardium Valvular Bioprosthesis
Impact of Mitral Regurgitation on Coronary Haemodynamics and Instantaneous Effect of Transcatheter Mitral Valve Repair
The CorCinch - Functional Mitral Valve Regurgitation (FMR) Study
Ertugliflozin for Functional Mitral Regurgitation
Clinical Outcomes of Edwards Lifesciences MITRIS RESLILA Mitral Valve in the Asian Population
A Study of Mitral Annular Disjunction in Mitral Valve Prolapse Patients and Arrhythmia Risk
Annular Reshaping of the Mitral Valve for Patients With Mitral Regurgitation Using the Millipede IRIS System